嘉欣丝绸：接受华福证券等投资者调研

Group 1 - The core viewpoint of the article highlights that Jiaxin Silk (SZ 002404) has engaged in investor research, with the company secretary participating in the discussions [1] - For the first half of 2025, Jiaxin Silk's revenue composition shows that silk and clothing-related businesses account for 99.9% of total revenue, while other businesses contribute only 0.1% [1] - As of the report, Jiaxin Silk's market capitalization stands at 4.1 billion yuan [1] Group 2 - The article also mentions a significant issue in the pharmaceutical industry, specifically the abuse of pregabalin leading to addiction cases, marking the first report of such incidents in the domestic market [1] - It points out vulnerabilities in online platforms that allow the purchase of medications without proper medical records, raising concerns about regulatory oversight [1]